 | Up a level |
Bertaggia-Calderara, D; Kröll, Dino; Gerschheimer, C; Nicolas, N; Nett, Philipp C.; Stirnimann, Guido; Alberio, L (2018). Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients. International journal of laboratory hematology, 40(1), e11-e14. Blackwell Scientific Publications 10.1111/ijlh.12767
Studt, J-D; Alberio, L; Angelillo, Anne; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of thrombosis and haemostasis, 15(8), pp. 1576-1583. Wiley-Blackwell 10.1111/jth.13747
Bulla, O; Poncet, A; Alberio, L; Asmis, L M; Gähler, A; Graf, L; Nagler, Michael; Studt, J-D; Tsakiris, D A; Fontana, P (2017). Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study. Haemophilia, 23(4), e335-e339. Wiley 10.1111/hae.13250
Schmid, P; Mordasini, A; Luginbühl, M; Regli, B; Kohler, H P; Zimmermann, H; Inderbitzin, D; Hirt, A; Lämmle, B; Alberio, L (2011). Low-dose recombinant factor VIIa for massive bleeding: A single centre observational cohort study with 73 patients. Swiss medical weekly, 141, w13213. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13213
Asmis, L M; Alberio, L; Angelillo-Scherrer, A; Korte, W; Mendez, A; Reber, G; Seifert, B; Stricker, H; Tsakiris, D A; Wuillemin, W A (2011). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis research, 129(4), pp. 492-498. Amsterdam: Elsevier 10.1016/j.thromres.2011.06.031
Luginbühl, R; Barizzi, G; Sulzer, I; Lämmle, B; Alberio, L (2010). Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA. International journal of laboratory hematology, 33(2), pp. 168-175. Oxford: Blackwell Scientific Publications 10.1111/j.1751-553X.2010.01262.x
Schneiter, S; Colucci, G; Sulzer, I; Barizzi, G; Lämmle, B; Alberio, L (2009). Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA. Journal of thrombosis and haemostasis, 7(10), pp. 1649-55. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2009.03507.x
Colucci, G; Lämmle, B; Alberio, L (2009). Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: reply to a rebuttal. Journal of thrombosis and haemostasis, 7(10), pp. 1755-1756. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2009.03517.x
Warncke, C; Alberio, L; Savolainen, H; von Allmen, R; Baumgartner, I; Husmann, M (2008). "HIT on Trousseau" double trouble: acquired coagulopathy with femoral artery thrombosis. Vasa - European journal of vascular medicine, 37(3), pp. 281-4. Bern: Huber 10.1024/0301.1526.37.3.281
Alberio, L; Lämmle, B (2008). Stability of coagulation assays performed in plasma from citrated whole blood transportet at ambient temperatur: only a part of the story. Reply to E. J. Favoloro. Thrombosis and haemostasis, 99(8), p. 1123. Stuttgart: Schattauer 10.1160/TH08-05-0279
Tiede, A; Huth-Kühne, A; Oldenburg, J; Grossmann, R; Geisen, U; Krause, M; Brand, B; Alberio, L; Klamroth, R; Spannagl, M; Knöbl, P (2008). Erhebung zur immunsuppressiven Therapie der erworbenen Hämophilie in Deutschland, Österreich und der Schweiz. Hämostaseologie, 28(Suppl1), pp. 29-30. Stuttgart: Schattauer
Stricker, H; Colucci, G; Alberio, L; Mombelli, G (2006). Variation in coagulation inhibitors during prolonged sitting: possible pathogenetic mechanisms for travel-associated thrombosis. Journal of thrombosis and haemostasis, 4(4), pp. 900-2. Oxford: Blackwell 10.1111/j.1538-7836.2006.01855.x
Alberio, L; Clemetson, KJ (2005). [Platelet inhibition and activation. Mechanisms and clinical implications.]. Herz, 30(3), pp. 176-80. München: Urban & Vogel 10.1007/s00059-005-2681-x
Alberio, L; Friese, P; Clemetson, KJ; Dale, GL (2002). Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo. Thrombosis and haemostasis, 88(3), pp. 510-6. Stuttgart: Schattauer
Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L (2002). Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature, 6868(415), pp. 175-9. London: Macmillan Journals Ltd. 10.1038/415175a
Alberio, L; Safa, O; Clemetson, KJ; Esmon, CT; Dale, GL (2000). Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood, 95(5), pp. 1694-702. Washington, D.C.: American Society of Hematology
